India, Nov. 5 -- The United States Food and Drug Administration tentatively approved earlier this week a generic form of lenacapavir made by Dr. Reddy’s Laboratories, but Doctors Without Borders/Médecins Sans Frontières said on Nov. 5, 2026 that people in dozens of countries will still be locked out of affordable access due to Gilead Sciences’ licensing restrictions.
Approval and product details
Doctors Without Borders/Médecins Sans Frontières said the tentative approval is “welcome news” and described lenacapavir as a “highly effective, twice-yearly injectable form of HIV prevention.” The organization said Gilead Sciences, a US-based pharmaceutical corporation, makes lenacapavir.
Doctors Without Borders/Médecins Sans Frontières said Gil...